Immunomodulation of cuproptosis and ferroptosis in liver cancer

Jia-qian Mo,Shen-yan Zhang,Qiang Li,Mo-xian Chen,Yue-qing Zheng,Xin Xie,Rongxin Zhang,Shan-shan Wang

DOI: https://doi.org/10.1186/s12935-023-03207-y

IF: 6.429

2024-01-10

Cancer Cell International

Abstract:Abstract According to statistics, the incidence of liver cancer is increasing yearly, and effective treatment of liver cancer is imminent. For early liver cancer, resection surgery is currently the most effective treatment. However, resection does not treat the disease in advanced patients, so finding a method with a better prognosis is necessary. In recent years, ferroptosis and cuproptosis have been gradually defined, and related studies have proved that they show excellent results in the therapy of liver cancer. Cuproptosis is a new form of cell death, and the use of cuproptosis combined with ferroptosis to inhibit the production of hepatocellular carcinoma cells has good development prospects and is worthy of in-depth discussion by researchers. In this review, we summarize the research progress on cuproptosis combined with ferroptosis in treating liver cancer, analyze the value of cuproptosis and ferroptosis in the immune of liver cancer, and propose potential pathways in oncotherapy with the combination of cuproptosis and ferroptosis, which can provide background knowledge for subsequent related research.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the immunomodulatory roles of cuproptosis and ferroptosis in the treatment of liver cancer. Specifically, the paper focuses on the following aspects:

1. **The relationship between cuproptosis, ferroptosis and cancer**: The paper points out that cuproptosis and ferroptosis are forms of programmed cell death and are closely related to the occurrence and development of cancer.

2. **The role of the tumor microenvironment**: The paper emphasizes the crucial role of the immune microenvironment in the occurrence and development of liver cancer. The complex structure and function of the tumor microenvironment play an important role in tumor development.

3. **The value of cuproptosis and ferroptosis in liver cancer immunity**: The paper analyzes the value of cuproptosis and ferroptosis in liver cancer immunity and explores how these two forms of cell death can inhibit the development of liver cancer by influencing the immune system.

4. **The potential treatment approaches of cuproptosis and ferroptosis**: The paper proposes potential approaches of combining cuproptosis and ferroptosis in the treatment of liver cancer, providing background knowledge for subsequent related research.

In summary, the main purpose of this paper is to summarize the research progress of cuproptosis and ferroptosis in the treatment of liver cancer, analyze their roles in liver cancer immunity, and propose potential approaches of combining these two forms of cell death in tumor treatment. This not only helps to deeply understand the pathogenesis of liver cancer but also provides a theoretical basis for the development of new treatment methods.